Bayer AG said Wednesday that research-and-development investments in its agricultural business is expected to fuel mid- and long-term growth at the company, with the potential for the business to bring in up to 30 billion euros ($34.08 billion) over the next two decades.
The German pharmaceutical-and-agricultural company also said a technology it developed to improve corn farming, which it has named Short Stature Corn, is expected to generate an incremental peak sales opportunity of about EUR1 billion in North America.
Bayer is advancing in its development of seeds and products for crop protection, and is having pest-control and fungicides products progress to next development phases, it said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.